Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Dec 09, 2021 7:57pm
237 Views
Post# 34216792

Todays House Positions

Todays House Positions
House Positions for C:ARCH from 20211209 to 20211209
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 41,500 170,944 4.119 0   41,500 -170,944
83 Mackie 30,000 119,700 3.99 0   30,000 -119,700
9 BMO Nesbitt 22,710 90,874 4.001 2,020 8,498 4.207 20,690 -82,376
80 National Bank 6,961 29,120 4.183 1,152 4,781 4.15 5,809 -24,339
124 Questrade 7,240 29,504 4.075 2,022 8,569 4.238 5,218 -20,935
79 CIBC 28,686 118,766 4.14 24,226 98,556 4.068 4,460 -20,210
72 Credit Suisse 1,500 6,125 4.083 0   1,500 -6,125
85 Scotia 3,223 13,244 4.109 2,826 11,717 4.146 397 -1,527
39 Merrill Lynch 353 1,429 4.048 0   353 -1,429
57 Interactive 326 1,343 4.12 100 421 4.21 226 -922
33 Canaccord 700 2,800 4.00 700 2,793 3.99 0 -7
14 ITG 461 1,914 4.152 478 1,947 4.073 -17 33
19 Desjardins 0   100 401 4.01 -100 401
13 Instinet 400 1,610 4.025 500 2,100 4.20 -100 490
84 Ind Trading 0   156 651 4.173 -156 651
53 Morgan Stanley 0   349 1,386 3.971 -349 1,386
2 RBC 3,850 15,647 4.064 4,325 18,861 4.361 -475 3,214
68 Leede 474 1,926 4.063 1,926 8,027 4.168 -1,452 6,101
88 Credential 0   1,570 6,391 4.071 -1,570 6,391
18 Echelon 2,000 8,040 4.02 8,500 36,346 4.276 -6,500 28,306
1 Anonymous 86,292 355,150 4.116 118,100 483,079 4.09 -31,808 127,929
7 TD Sec 40,570 164,260 4.049 108,196 437,874 4.047 -67,626 273,614
TOTAL 277,246 1,132,396 4.084 277,246 1,132,398 4.084 0 2
 
 
<< Previous
Bullboard Posts
Next >>